Supplemental Material - Comparison of comorbidities and adverse events in dermatology and rheumatology patients prescribed tofacitinib: a retrospective analysis

Name: Supplemental Material - Comparison of comorbidities and adverse events in dermatology and rheumatology patients prescribed tofacitinib: a retrospective analysis
Creator: Carli Needle
Published: 2023-11-21T08:35:39.655Z
Keywords: Dermatology, Infectious Disease, Rheumatology, Adverse Effect of Drug, Drug Safety, Janus Kinase

Needle, Carli; Klein, Elizabeth; Gjonaj, Jessica; Nohria, Ambika; Karim, Maria; Liu, Lynn; Shah, Jinal; Betensky, Rebecca; Garshick, Michael; Lo Sicco, Kristen; Karagounis, Theodora

doi:10.17632/wbvrdw2x2x.2

Supplemental Material - Comparison of comorbidities and adverse events in dermatology and rheumatology patients prescribed tofacitinib: a retrospective analysis

Published: 21 November 2023| Version 2 | DOI: 10.17632/wbvrdw2x2x.2

Contributors:

Carli Needle, Elizabeth Klein, Jessica Gjonaj, Ambika Nohria, Maria Karim, Lynn Liu, Jinal Shah, Rebecca Betensky, Michael Garshick, Kristen Lo Sicco, Theodora Karagounis

Description

Supplemental methods and results for the publication entitled, “Comparison of comorbidities and adverse events in dermatology and rheumatology patients prescribed tofacitinib: a retrospective analysis.”

Files

Institutions

NYU Langone Health

Supplemental Material - Comparison of comorbidities and adverse events in dermatology and rheumatology patients prescribed tofacitinib: a retrospective analysis

Description

Files

Institutions

Categories

Licence